EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Mass Spectrometry-Based Comparative Analysis of N -Glycosylation Alterations in Three Human Body Fluids in Parkinson’s Disease

Lingbo Zhao, Chunyan Hou iD, Yu Gao, Hong Jin, Chun-Feng Liu iD, Shuwei Li, Junfeng Ma iD, Shuang Yang iD

ACS Chemical Neuroscience · 2025

DOI: 10.1021/acschemneuro.5c00654 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift ACS Chemical Neuroscience, 2025. Verfasst von Lingbo Zhao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center for Clinical Mass Spectrometry, School of Pharmaceutical Sciences, Soochow University, Suzhou, Jiangsu 215123, China. Hauptthemen laut MEDLINE: Parkinson Disease, Glycoproteins, Body Fluids. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Priority Academic Program Development of Jiangsu Higher Education Institutions, Shantou University Medical College, Neurological Disease Research Centre of the Second Hospital of Soochow University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Parkinson's disease (PD) is a progressive neurodegenerative disorder lacking definitive diagnostic tests. To identify new diagnostic biomarkers, we employed glycoproteomics-mass spectrometry (MS) to investigate dynamic changes in protein N-glycosylation across the serum, urine, and saliva of PD patients. Our comparative analysis of differentially expressed glycoproteins (DEGs) between PD patients and healthy controls (HCs) revealed distinct patterns. Specifically, ATPase phospholipid transporter 11B (ATP11B) was significantly upregulated in the serum of PD patients, while urine and saliva showed an opposite trend. Other key findings included elevated myeloperoxidase (MPO) in urine and clusterin (CLU) in serum. Zinc-α-2-glycoprotein (AZGP1), detected in all three biofluids, displayed increased sialylation and core fucosylation in serum but decreased levels in the saliva and urine of PD patients, along with a distinct bifucosylation pattern in saliva. These glycoprotein expression changes were further validated using enzyme-linked immunoassay (ELISA). Pathway analysis indicated that these DEGs are primarily involved in inflammatory response, complement activation, and synaptic plasticity, suggesting that glycosylation dysregulation may contribute to PD progression by modulating neuroinflammation and protein homeostasis. This study represents the first comprehensive analysis of multibiofluid N-glycosylation in PD. The findings offer potential biomarkers and provide insights into the molecular mechanisms of the disease, which could ultimately inform early diagnosis and the development of targeted therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseGlycoproteinsBody FluidsHumansGlycosylationMaleFemaleMiddle AgedAgedBiomarkersMass SpectrometrySalivaClusterinProteomics

Stichwörter der Autor:innen

Parkinson’s diseaseglycosylationmass spectrometrysalivaserumurine

Substanzen

BiomarkersClusterinGlycoproteins

Autor:innen und Institutionen

  • Center for Clinical Mass Spectrometry, School of Pharmaceutical Sciences, Soochow University, Suzhou, Jiangsu 215123, China.
  • Department of Respiratory Medicine, The Fourth Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215123, China.
  • Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown UniversityMedical Center, Georgetown University, Washington, District of Columbia 20057, United States.
  • Department of Neurology and Clinical Research Center of Neurological Disease, The Second Affiliated Hospital of Soochow University, Suzhou 215004, China.
  • Nanjing Apollomics Biotech, Inc., Nanjing, Jiangsu 210033, China.
  • Laboratory of Clinical and Molecular Glycobiology, Institute of Glycomics, Shantou University Medical College, Shantou, Guangdong 515041, China.

ORCID-Profile: Chunyan Hou, Chun-Feng Liu, Junfeng Ma, Shuang Yang

Förderung

  • Priority Academic Program Development of Jiangsu Higher Education Institutions
  • Shantou University Medical College
  • Neurological Disease Research Centre of the Second Hospital of Soochow University
  • Jiangsu Shuangchuang Boshi Funding
  • Suzhou Medical Innovation Funding
  • Jiangsu Science and Technology Plan Funding
  • Suzhou Science and Technology

Zitieren

APA

Zhao, L., Hou, C., Gao, Y., Jin, H., Liu, C. F., Li, S., Ma, J., & Yang, S. (2025). Mass Spectrometry-Based Comparative Analysis of N -Glycosylation Alterations in Three Human Body Fluids in Parkinson’s Disease. ACS Chemical Neuroscience. https://doi.org/10.1021/acschemneuro.5c00654

Vancouver

Zhao L, Hou C, Gao Y, Jin H, Liu CF, Li S, et al. Mass Spectrometry-Based Comparative Analysis of N -Glycosylation Alterations in Three Human Body Fluids in Parkinson’s Disease. ACS Chemical Neuroscience. 2025. doi:10.1021/acschemneuro.5c00654

BibTeX
@article{Zhao2025,
  author = {Zhao, Lingbo and Hou, Chunyan and Gao, Yu and Jin, Hong and Liu, Chun-Feng and Li, Shuwei and Ma, Junfeng and Yang, Shuang},
  title = {Mass Spectrometry-Based Comparative Analysis of N -Glycosylation Alterations in Three Human Body Fluids in Parkinson’s Disease},
  journal = {ACS Chemical Neuroscience},
  year = {2025},
  doi = {10.1021/acschemneuro.5c00654}
}
Kostenlos starten →